NMIN
PEOPLE
NMIN leverages the research and entrepreneurial excellence of a pan-Canadian, multidisciplinary team.
NMIN’s Board of Directors (BoD) provides governance and monitors progress towards strategic goals. The BoD receives input from two Advisory Committees: the Executive & Nominating Committee, and the Finance & Audit Committee.
NMIN’s Management Team consists of the Scientific Director & CEO, the Associate Scientific Director, and the Executive Director.
NMIN’s Research program receives oversight and strategic direction from the Research Management Committee (RMC). Each of the program’s three Themes and two Core Facilities are further overseen by two Co-leaders.
The RMC receives input from three committees: the KTEE Advisory Committee, the HQP Program Advisory Committee, and the Executive Committee of the NMIN HQP Network (NHN).
The Administrative Centre Team provides support to the Research and the HQP programs, and implements the network’s administration, operations, IP, and communications cores on a day-to-day basis.

NMIN
GOVERNANCE
Board of Directors
NMIN’s Board of Directors (BoD) provides governance and monitors progress towards strategic goals.
The BoD includes 10 individuals with leadership experience in areas ranging from law to corporate management. Committees of the Board include the Board Executive, Board Nomination, Audit and Finance, Conflict of Interest, and Ethics Advisory committees. Members of the BoD also form adhoc committees or special task forces as needed.

CHAIR: Don Enns
Vice President and Head of Global Drug Delivery, Evonik Industries

Helen Burt
Associate Vice-President Research & Innovation, UBC

Chad Bayne
Partner, Emerging and High Growth Companies, Osler

Christine Charette
Managing Director, Scientia Advisors & Investments

Michael Coughtrie
Professor and Dean, Faculty of Pharmaceutical Sciences, UBC

CHAIR: Don Enns
Vice President and Head of Global Drug Delivery, Evonik Industries

Chad Bayne
Partner, Emerging and High Growth Companies, Osler

Helen Burt
Associate Vice-President Research & Innovation, UBC

Christine Charette
Managing Director, Scientia Advisors & Investments

Pieter Cullis
Scientific Director & CEO, NMIN

Lesley Esford
Director, Innovate BC

Vanessa Grant
Partner, Norton Rose Fulbright Canada LLP

Inès Holzbaur
Co-Founder & Managing Partner, AmorChem

David Martin
Managing Director & Head of Equity Research, Bloom Burton Securities

Norma Sebestyen
Ex-Director of Policy and Patient Access, Merck

Michael Coughtrie
Professor and Dean, Faculty of Pharmaceutical Sciences, UBC

Pieter Cullis
Scientific Director & CEO, NMIN

Lesley Esford
Director, Innovate BC

Vanessa Grant
Partner, Norton Rose Fulbright Canada LLP

Inès Holzbaur
Co-Founder & Managing Partner, AmorChem

David Martin
Managing Director & Head of Equity Research, Bloom Burton Securities

Norma Sebestyen
Ex-Director of Policy and Patient Access, Merck

Rebecca Yu
Vice President, Market Access and External Affairs, Takeda Canada
NMIN
NETWORK MANAGEMENT
Management Team
NMIN’s Scientific Leadership Team is comprised of the Scientific Director, the Associate Scientific Director, and the Executive Director, who provide strategic leadership and overall management.

Pieter Cullis
Scientific Director & CEO

Christine Allen
Associate Scientific Director

Gilbert Walker
Associate Scientific Director

Diana Royce
Executive Director

Pieter Cullis
Scientific Director & CEO

Christine Allen
Associate Scientific Director

Gilbert Walker
Associate Scientific Director

Diana Royce
Executive Director
NMIN
research MANAGEMENT
Research Management Committee
With representatives from academic and industry partners, the Research Management Committee (RMC) is responsible for ongoing assessment of all projects and provides recommendations to the BoD regarding research priorities and budget allocations.
The RMC receives input from three committees: the KTEE Advisory Committee, the HQP Program Advisory Committee (HPAC), and the Executive Committee of the NMIN HQP Network (NHN).

Marcel Bally
Theme 1 & PharmaCore Leader
University of British Columbia

Pieter Cullis
Theme 2 & NanoCore Leader, Scientific Director & CEO
University of British Columbia

Christian Kastrup
Theme 2 & NanoCore Co-Leader
University of British Columbia

Shana Kelley
Theme 3 Leader
University of Toronto

Marcel Bally
Theme 1 & PharmaCore Leader
University of British Columbia

Pieter Cullis
Theme 2 & NanoCore Leader, Scientific Director & CEO
University of British Columbia

Christian Kastrup
Theme 2 & NanoCore Co-Leader
University of British Columbia

Shyh-Dar (Star) Li
Theme 1 & PharmaCore Co-Leader
University of British Columbia

Parimal Nathwani
External
MaRS Innovation

David O’Neill
External
FACIT

Gilbert Walker
Theme 3 Co-Leader & Associate Scientific Director
University of Toronto

Shana Kelley
Theme 3 Leader
University of Toronto

Shyh-Dar (Star) Li
Theme 1 & PharmaCore Co-Leader
University of British Columbia

Norbert Maurer
External
Evonik Transferra

Parimal Nathwani
External
MaRS Innovation

Kaley Wilson
External
Quark Venture

Christine Charette
Observer
NMIN Board Member

Nancy Dos Santos
Observer
PharmaCore Operational Lead

Mark Pereira
Observer
Theme 3 Accelerator

David O’Neill
External
FACIT

Gilbert Walker
Theme 3 Co-Leader & Associate Scientific Director
University of Toronto

Kaley Wilson
External
Quark Venture

Christine Charette
Observer
NMIN Board Member

Sams Sadat
Observer
NHN Vice-President

Heather Mustoe
Observer
NCE Secretariat

Dominik Witzigmann
Observer
NanoCore Operational Lead

Nancy Dos Santos
Observer
PharmaCore Operational Lead

Mark Pereira
Observer
Theme 3 Accelerator

Heather Mustoe
Observer
NCE Secretariat

Dominik Witzigmann
Observer
NanoCore Operational Lead
Research Theme & Core Facilities Leaders
NMIN research is organized into three themes, led by Theme Leaders: Targeted Drug Delivery, Gene Therapy, and Diagnostics, each consisting of up to 10 projects. The research themes are supported by two core facilities led by Core Leaders: NanoCore and PharmaCore
Theme 1: Targeted Drug Delivery
Theme 2: Gene Therapy

Marcel Bally
Theme Leader
University of British Columbia

Shyh-Dar (Star) Li
Theme Co-Leader
University of British Columbia

Pieter Cullis
Theme Leader & Scientific Director
University of British Columbia

Christian Kastrup
Theme Co-leader
University of British Columbia
Theme 1: Targeted Drug Delivery

Marcel Bally
Theme Leader
University of British Columbia

Shyh-Dar (Star) Li
Theme Co-Leader
University of British Columbia
Theme 2: Gene Therapy

Pieter Cullis
Theme Leader & Scientific Director
University of British Columbia

Christian Kastrup
Theme Co-leader
University of British Columbia
Theme 3: Diagnostics
HQP Program

Shana Kelley
Theme Leader
University of Toronto

Gilbert Walker
Theme Co-Leader & Associate Scientific Director
University of Toronto

Mark Pereira
Theme Accelerator
University of Toronto

Christine Allen
HQP & Capacity Building Leader & Associate Scientific Director
University of Toronto
Theme 3: Diagnostics
HQP Program

Shana Kelley
Theme Leader
University of Toronto

Gilbert Walker
Theme Co-Leader & Associate Scientific Director
University of Toronto

Mark Pereira
Theme Accelerator
University of Toronto
NanoCore
PharmaCore

Pieter Cullis
Core Leader & Scientific Director
University of British Columbia

Christian Kastrup
Core Co-Leader
University of British Columbia

Dominik Witzigmann
Core Operational Lead
University of British Columbia

Marcel Bally
Core Leader
University of British Columbia

Shyh-Dar (Star) Li
Core Co-Leader
University of British Columbia

Nancy Dos Santos
Core Operational Lead
BC Cancer Agency
NanoCore

Pieter Cullis
Core Leader & Scientific Director
University of British Columbia

Christian Kastrup
Core Co-Leader
University of British Columbia

Dominik Witzigmann
NanoCore Operational Lead
University of British Columbia
PharmaCore

Marcel Bally
Core Leader
University of British Columbia

Shyh-Dar (Star) Li
Core Co-Leader
University of British Columbia

Nancy Dos Santos
Core Operational Lead
BC Cancer Agency
NMIN
administration
Administrative Centre Team
The Administrative Centre team consists of the Executive Director, the Executive Assistant, the Finance Manager, the Research and Partnerships manager, the HQP & Events Coordinator, and the Digital Initiatives Consultant. This team supports and facilitates the work of the network’s Governance, Management and Program teams, and is responsible for the network’s day-to-day operations.

Diana Royce
Executive Director
dianaroyce@nanomedicines.ca
Maria Barros
Executive Assistant
mariabarros@nanomedicines.ca
Marshall Beck
Digital Initiatives Consultant
mbeck@nanomedicines.ca
Leah Graystone
HQP & Events Coordinator
leahgraystone@nanomedicines.ca
Andrew Kim
Accountant
andrewkim@nanomedicines.ca
Daniel Rogers
Manager, Research & Partnerships
danrogers@nanomedicines.ca
NMIN
CONTACT
NMIN
2350 Health Sciences Mall, Room 5451
University of British Columbia
Vancouver, BC V6T 1Z3
Canada